MD Virologist,

Thanks for reminding us of that. I would say more generally that there are still a very few who keep abreast of these developments, relative to the larger medical community and certainly the general public.

Even with public statements and appropriate FDA evaluation, there is still more skepticism about the vaccine evaluation process than I would have expected.

I hope the same does not occur for leronlimab.

It is eminently unsettling when patients start doubting their physicians.